How many insider trades does FilingIQ track for CNTN?

FilingIQ tracks 8 Form 4 insider transactions for CNTN (Canton Strategic Holdings, Inc.), covering filings from May 22, 2026 onwards. 8 of those were filed in the last 90 days.

Are CNTN insiders net buyers or net sellers?

Across the full Form 4 history for CNTN, 0 transactions (0%) were open-market purchases and 8 (100%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CNTN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CNTN in?

Canton Strategic Holdings, Inc. (CNTN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $187.37M.

CNTN insider trading

NasdaqCM Healthcare

Canton Strategic Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 100%

Market cap

$187.37M

About Canton Strategic Holdings, Inc.

Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.

Company website: www.tharimmune.com

CNTN insider activity at a glance

FilingIQ has scored 8 insider transactions for CNTN since May 22, 2026. The most recent filing in our index is dated May 26, 2026.

Across the full history, 0 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CNTN insider trades is 58.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CNTN trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,265

UNITED THERAPEUTICS Corp

APLS 277

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 195

Guardant Health, Inc.

ADPT 184

Adaptive Biotechnologies Corp

BMY 182

BRISTOL MYERS SQUIBB CO

VTRS 165

Viatris Inc

ALNY 153

ALNYLAM PHARMACEUTICALS, INC.

Frequently asked

How many insider trades does FilingIQ track for CNTN?: FilingIQ tracks 8 Form 4 insider transactions for CNTN (Canton Strategic Holdings, Inc.), covering filings from May 22, 2026 onwards. 8 of those were filed in the last 90 days.
Are CNTN insiders net buyers or net sellers?: Across the full Form 4 history for CNTN, 0 transactions (0%) were open-market purchases and 8 (100%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CNTN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CNTN in?: Canton Strategic Holdings, Inc. (CNTN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $187.37M.

Methodology & sources

Every CNTN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.